Badi Abdulaziz Said Al, Hashar Amna Al, Riyami Intisar Al, Za'abi Mohammed Al
MSc, Department of Pharmacy, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman.
PhD. Department of Pharmacy, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman.
Pharm Pract (Granada). 2022 Jul-Sep;20(3):2693. doi: 10.18549/PharmPract.2022.3.2693. Epub 2022 Aug 23.
Since their introduction as adjunct anticonvulsants, the use of gabapentinoids (gabapentin and pregabalin) has increased substantially worldwide to include a wide range of clinical conditions. Various reports have demonstrated that they possess addiction liability and can produce effects similar to traditional recreational drugs, such as significant euphoric effects, enhanced sociability, and relaxation. However, there is limited information on the use of these agents in the Middle East.
Here, we describe the usage pattern of gabapentinoids at Sultan Qaboos University Hospital, a tertiary care medical institution in Oman.
Adult patients (≥18 years) who were prescribed gabapentinoids for six months (March-August 2019) were included in this retrospective cross-sectional study. Indications and dosing regimens were reviewed according to the Food and Drug Administration labeling. Controlled and restricted drugs were reviewed using Oman National Formulary. Institutional ethical approval was obtained before conducting the study.
We analyzed 291 prescriptions. The mean (standard deviation, SD) age was 60.5 years (SD = 13.0) with the age group of ≥60 years being the most common (190, 65.3%). Most of patients were females (178, 61.2%). The majority of prescriptions were for outpatients (85.8%). Drugs were prescribed as refill and follow-up in 116 (40.0%) and 97 (33.4%) of prescriptions, respectively. Diabetic peripheral neuropathy (50, 79.4%) was the most labeled indication for both. Off-label use was 128 (51.8%) and 31 (70.5%) for pregabalin and gabapentin, respectively, with lower back pain as being the most common indication for both drugs. A total of 54 (19.0%) patients were using at least one of the psychotropic drugs.
Our findings indicate that gabapentinoids are frequently prescribed for off-label use. Awareness programs and the establishment of policy for the use of these drugs are required to ensure their rational use and prevent misuse and/or abuse.
自加巴喷丁类药物(加巴喷丁和普瑞巴林)作为辅助抗惊厥药物引入以来,其在全球范围内的使用量大幅增加,涵盖了广泛的临床病症。各种报告表明,它们具有成瘾性,能产生与传统消遣性药物相似的效果,如显著的欣快感、社交能力增强和放松感。然而,关于这些药物在中东地区使用情况的信息有限。
在此,我们描述阿曼一家三级医疗中心——苏丹·卡布斯大学医院加巴喷丁类药物的使用模式。
本回顾性横断面研究纳入了2019年3月至8月期间连续6个月开具加巴喷丁类药物处方的成年患者(≥18岁)。根据美国食品药品监督管理局的标签审查用药指征和给药方案。使用阿曼国家处方集审查管制和受限药物。在开展研究前获得了机构伦理批准。
我们分析了291份处方。平均(标准差,SD)年龄为60.5岁(SD = 13.0),≥60岁年龄组最为常见(190例,65.3%)。大多数患者为女性(178例,61.2%)。大多数处方为门诊处方(85.8%)。分别有116份(40.0%)和97份(33.4%)处方的药物用于续方和随访。糖尿病性周围神经病变(50例,79.4%)是两者最常见的标注适应证。普瑞巴林和加巴喷丁的超说明书用药分别为128例(51.8%)和31例(70.5%),下背部疼痛是两种药物最常见的超说明书用药适应证。共有54例(19.0%)患者使用了至少一种精神药物。
我们的研究结果表明,加巴喷丁类药物经常被超说明书用药。需要开展宣传项目并制定这些药物的使用政策,以确保其合理使用,防止滥用和/或误用。